Login / Signup
Frank R Lichtenberg
ORCID
Publication Activity (10 Years)
Years Active: 2020-2024
Publications (10 Years): 6
Top Topics
Childhood Cancer
Health Insurance
Clinical Practice
Drug Administration
Top Venues
Journal of pharmaceutical policy and practice
Expert review of pharmacoeconomics & outcomes research
International journal of health economics and management
Health economics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Frank R Lichtenberg
Do newer drugs treat fewer diseases, controlling for time since launch? Evidence from France and the U.S.
Journal of pharmaceutical policy and practice
17 (1) (2024)
Frank R Lichtenberg
Do newer drugs treat fewer diseases, controlling for time since launch? Evidence from France and the U.S.
Journal of pharmaceutical policy and practice
17 (1) (2024)
Frank R Lichtenberg
Has pharmaceutical innovation reduced the average cost of U.S. health care episodes?
International journal of health economics and management
(2023)
Frank R Lichtenberg
The impact of pharmaceutical innovation on the longevity and hospitalization of New Zealand cancer patients, 1998-2017.
Expert review of pharmacoeconomics & outcomes research
21 (3) (2021)
Frank R Lichtenberg
Are drug prices subject to creative destruction? Evidence from the US, 1997-2017.
Health economics
30 (8) (2021)
Frank R Lichtenberg
How cost-effective are new cancer drugs in the U.S.?
Expert review of pharmacoeconomics & outcomes research
20 (1) (2020)